These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38632600)

  • 21. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression.
    Wu LF; Zhou ZJ; Zeng YH; Yang SL; Zhang QY
    Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G485-G498. PubMed ID: 39259911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Assessment of the Effects of Sleeve Gastrectomy on Glucose, Lipid, and Amino Acid Metabolism in Asian Individuals with Morbid Obesity.
    Yao J; Kovalik JP; Lai OF; Lee PC; Eng A; Chan WH; Tham KW; Lim E; Bee YM; Tan HC
    Obes Surg; 2019 Jan; 29(1):149-158. PubMed ID: 30191503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of time-dependent alterations in adipokine levels and endoplasmic reticulum stress markers in obese patients with laparoscopic sleeve gastrectomy.
    Pakyurek H; Aykota MR; Kilic-Erkek O; Ozban M; Senol H; Bor-Kucukatay M
    Life Sci; 2023 Oct; 330():121987. PubMed ID: 37541576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system.
    Shera S; Katzka W; Yang JC; Chang C; Arias-Jayo N; Lagishetty V; Balioukova A; Chen Y; Dutson E; Li Z; Mayer EA; Pisegna JR; Sanmiguel C; Pawar S; Zhang D; Leitman M; Hernandez L; Jacobs JP; Dong TS
    Front Microbiol; 2024; 15():1407555. PubMed ID: 39184030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.
    Guo L; Zhang P; Chen Z; Xia H; Li S; Zhang Y; Kobberup S; Zou W; Lin JD
    J Clin Invest; 2017 Dec; 127(12):4449-4461. PubMed ID: 29106384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
    Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
    Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis.
    Wan Z; Liu X; Yang X; Huang Z; Chen X; Feng Q; Cao H; Deng H
    Cell Mol Life Sci; 2024 Sep; 81(1):398. PubMed ID: 39261317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer.
    Ma Y; Gao M; Liu D
    Sci Rep; 2016 May; 6():26242. PubMed ID: 27184920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing clinical and metabolic responses related to hyperlipidemia, MASLD and type 2 diabetes: sleeve versus RYGB.
    Bharatselvam S; Schwenger KJP; Ghorbani Y; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Nutrition; 2024 Oct; 126():112530. PubMed ID: 39111098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating adiponectin increases in obese women after sleeve gastrectomy or gastric bypass driving beneficial metabolic changes but with no relationship with carotid intima-media thickness.
    Gómez-Martin JM; Balsa JA; Aracil E; Insenser M; Priego P; Escobar-Morreale HF; Botella-Carretero JI
    Clin Nutr; 2018 Dec; 37(6 Pt A):2102-2106. PubMed ID: 29054470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity.
    Gilglioni EH; Li A; St-Pierre-Wijckmans W; Shen TK; Pérez-Chávez I; Hovhannisyan G; Lisjak M; Negueruela J; Vandenbempt V; Bauzá-Martinez J; Herranz JM; Ezeriņa D; Demine S; Feng Z; Vignane T; Otero Sanchez L; Lambertucci F; Prašnická A; Devière J; Hay DC; Encinar JA; Singh SP; Messens J; Filipovic MR; Sharpe HJ; Trépo E; Wu W; Gurzov EN
    Nat Commun; 2024 Nov; 15(1):9522. PubMed ID: 39496584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review.
    Ziqubu K; Dludla PV; Mthembu SXH; Nkambule B; Mazibuko-Mbeje SE
    Adipocyte; 2024 Dec; 13(1):2390833. PubMed ID: 39162358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice.
    Xia B; Yu R; Liu J; Liu D; Li S; Yang L; Liu N; Liang B; Zeng J; Wei J; Lin G
    Toxicol Lett; 2024 Jan; 391():100-110. PubMed ID: 38040069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    De Munck TJI; Boesch M; Verhaegh P; Masclee AAM; Jonkers D; van Pelt JF; du Plessis J; Korf H; Nevens F; Koek GH; Van der Merwe S; Verbeek J
    PLoS One; 2021; 16(5):e0251822. PubMed ID: 33989346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.
    Alsina ME; Ruiz-Tovar J; Bernabeu A
    Obes Surg; 2017 Jul; 27(7):1724-1728. PubMed ID: 27885531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.
    Fernández-Tussy P; Cardelo MP; Zhang H; Sun J; Price NL; Boutagy NE; Goedeke L; Cadena-Sandoval M; Xirouchaki CE; Brown W; Yang X; Pastor-Rojo O; Haeusler RA; Bennett AM; Tiganis T; Suárez Y; Fernández-Hernando C
    JCI Insight; 2024 Aug; 9(19):. PubMed ID: 39190492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
    Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
    Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.